Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Roche’s fenebrutinib demonstrates decade-first benefit in multiple sclerosis - European Pharmaceutical Review
Roche’s fenebrutinib demonstrates decade-first benefit in multiple sclerosis - European Pharmaceutical Review
Roche unveils data behind BTK inhibitor's phase 3 multiple sclerosis win in Ocrevus trial - Fierce Biotech
Roche unveils data behind BTK inhibitor's phase 3 multiple sclerosis win in Ocrevus trial - Fierce Biotech
Genentech cut at least 489 jobs last year, new filing reveals - Fierce Biotech
Genentech cut at least 489 jobs last year, new filing reveals - Fierce Biotech
Roche continues RNA return with $1.7B deal for Sanegene drug - Fierce Biotech
Roche continues RNA return with $1.7B deal for Sanegene drug - Fierce Biotech
Roche Expands Clinical Research in Mexico, Invests MX$1.2 Billion - Mexico Business News
Roche Expands Clinical Research in Mexico, Invests MX$1.2 Billion - Mexico Business News